Literature DB >> 25043804

Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.

Nathalie Doorenweerd1, Chiara S Straathof, Eve M Dumas, Pietro Spitali, Ieke B Ginjaar, Beatrijs H Wokke, Debby G Schrans, Janneke C van den Bergen, Erik W van Zwet, Andrew Webb, Mark A van Buchem, Jan J Verschuuren, Jos G Hendriksen, Erik H Niks, Hermien E Kan.   

Abstract

OBJECTIVE: Duchenne muscular dystrophy (DMD) is characterized by progressive muscle weakness caused by DMD gene mutations leading to absence of the full-length dystrophin protein in muscle. Multiple dystrophin isoforms are expressed in brain, but little is known about their function. DMD is associated with specific learning and behavioral disabilities that are more prominent in patients with mutations in the distal part of the DMD gene, predicted to affect expression of shorter protein isoforms. We used quantitative magnetic resonance (MR) imaging to study brain microstructure in DMD.
METHODS: T1-weighted and diffusion tensor images were obtained on a 3T MR scanner from 30 patients and 22 age-matched controls (age = 8-18 years). All subjects underwent neuropsychological examination. Group comparisons on tissue volume and diffusion tensor imaging parameters were made between DMD patients and controls, and between 2 DMD subgroups that were classified according to predicted Dp140 isoform expression (DMD_Dp140(+) and DMD_Dp140(-) ).
RESULTS: DMD patients had smaller total brain volume, smaller gray matter volume, lower white matter fractional anisotropy, and higher white matter mean and radial diffusivity than healthy controls. DMD patients also performed worse on neuropsychological examination. Subgroup analyses showed that DMD_Dp140(-) subjects contributed most to the gray matter volume differences and performed worse on information processing.
INTERPRETATION: Both gray and white matter is affected in boys with DMD at a whole brain level. Differences between the DMD_Dp140(-) subgroup and controls indicate an important role for the Dp140 dystrophin isoform in cerebral development.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043804     DOI: 10.1002/ana.24222

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

1.  The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy.

Authors:  Mathula Thangarajh; Gary L Elfring; Panayiota Trifillis; Joseph McIntosh; Stuart W Peltz
Journal:  Neurology       Date:  2018-08-22       Impact factor: 9.910

2.  Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.

Authors:  Ulrich Lindberg; Nanna Witting; Stine Lundgaard Jørgensen; John Vissing; Egill Rostrup; Henrik Bo Wiberg Larsson; Christina Kruuse
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  Neurocognitive Impairment in mdx Mice.

Authors:  Clarissa M Comim; Letícia Ventura; Viviane Freiberger; Paula Dias; Daiane Bragagnolo; Matheus L Dutra; Ricardo A Amaral; Ana Lucia S Camargo-Fagundes; Patrícia A Reis; Hugo C Castro-Faria-Neto; Mariz Vainzof; Maria I Rosa
Journal:  Mol Neurobiol       Date:  2019-05-10       Impact factor: 5.590

4.  Comprehensive analysis of the expression profile of circRNAs and their predicted protein-coding ability in the muscle of mdx mice.

Authors:  Zubiao Song; Yanmei Liu; Xiaobo Fang; Mengshu Xie; Zhenyu Ma; Zhigang Zhong; Xuelin Feng; Weixi Zhang
Journal:  Funct Integr Genomics       Date:  2019-11-18       Impact factor: 3.410

5.  In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.

Authors:  V Preethish-Kumar; A Shah; M Kumar; M Ingalhalikar; K Polavarapu; M Afsar; J Rajeswaran; S Vengalil; S Nashi; P T Thomas; A Sadasivan; M Warrier; A Nalini; J Saini
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

6.  Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy.

Authors:  Abbe H Crawford; John C W Hildyard; Sophie A M Rushing; Dominic J Wells; Maria Diez-Leon; Richard J Piercy
Journal:  Dis Model Mech       Date:  2022-03-02       Impact factor: 5.758

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; Mary K Colvin; Linda Cripe; Adrienne R Herron; Annie Kennedy; Kathi Kinnett; James Naprawa; Garey Noritz; James Poysky; Natalie Street; Christina J Trout; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-02       Impact factor: 44.182

8.  Diffusion tensor imaging study in Duchenne muscular dystrophy.

Authors:  Ya Fu; Yuru Dong; Chao Zhang; Yu Sun; Shu Zhang; Xuetao Mu; Hong Wang; Weihai Xu; Shiwen Wu
Journal:  Ann Transl Med       Date:  2016-03

9.  Relationships between DMD mutations and neurodevelopment in dystrophinopathy.

Authors:  Mathula Thangarajh; Jos Hendriksen; Michael P McDermott; William Martens; Kimberly A Hart; Robert C Griggs
Journal:  Neurology       Date:  2019-10-08       Impact factor: 9.910

10.  Longitudinal motor function in proximal versus distal DMD pathogenic variants.

Authors:  Mathula Thangarajh; Luca Bello; Heather Gordish-Dressman
Journal:  Muscle Nerve       Date:  2021-07-23       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.